Christos SOTIRIOU
Inventor
Stats
- 1 US patents issued
- 9 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 9 US Applications Filed
- 32 Total Citation Count
- May 17, 2017 Most Recent Filing
- Oct 30, 2007 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
UNIVERSITE LIBRE DE BRUXELLES | 1
2 3 1 2 1 | 2007
2008 2010 2011 2012 2013 |
Inventor Addresses
Address | Duration |
---|---|
Brussels, BE | Nov 06, 08 - Nov 06, 08 |
Bruxelles, BE | Nov 25, 10 - Nov 14, 19 |
UCCLE, BE | Feb 17, 11 - Feb 17, 11 |
Uccle, BE | Nov 12, 13 - Feb 27, 14 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 2 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 2 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2019/0345,558 | 2019 | METHOD FOR DETERMINING SENSITIVITY TO A CDK4/6 INHIBITOR | 4 |
2014/0056,881 | 2014 | METHOD AND KIT FOR THE DETECTION OF GENES ASSOCIATED WITH PIK3CA MUTATION AND INVOLVED IN PI3K/AKT PATHWAY ACTIVATION IN THE ER-POSTITIVE AND HER2-POSITIVE SUBTYPES WITH CLINICAL IMPLICATIONS | 0 |
8580496 | 2013 | Method and kit for the detection of genes associated with PIK3CA mutation and involved in PI3K/AKT pathway activation in the ER-postitive and HER2-positive subtypes with clinical implications | 0 |
2013/0296,328 | 2013 | EPIGENETIC PORTRAITS OF HUMAN BREAST CANCERS | 3 |
2012/0071,346 | 2012 | GENE-BASED ALGORITHMIC CANCER PROGNOSIS | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.